TACE Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Colorectal Cancer (CRC)
Clinical trial NCT04873895 · TERMINATED
Trial details
- NCT number
- NCT04873895
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-24
- Primary completion
- 2024-04-25
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.